Navigation Links
John Theurer Cancer Center presents studies on promising therapies for aggressive blood cancers
Date:12/7/2010

latrexate Effective in Patients with T-cell Lymphoma who Fail ICE-Based Regimens? (Abstract number #1753; poster session, December 4, 5:30-7:30 p.m.)

Andre Goy, M.D., M.S., Deputy Director and Chief, Lymphoma and Director, Clinical and Translational Cancer Research, John Theurer Cancer Center, and colleagues analyzed data from the phase II pivotal trial of pralatrexate (known as the PROPEL study) which led to the FDA approval of pralatrexate in September 2009.

The goal of the study was to determine the outcome of the subset of patients with Peripheral T-Cell Lymphoma (PTCL) who had previously received and failed or relapsed after ICE chemotherapy. ICE is a combination of ifosfamide, carboplatin and etoposide, currently used as standard salvage therapy in patients with PTCL in preparation of high dose therapy followed by autologous stem cell transplantation.

PTCL is an especially aggressive cancer that attacks immune cells that protect the body from viruses. It is typically resistant to second-line treatments, such as ICE regimens.

Forty percent of study patients treated with pralatrexate showed a partial or complete response. The authors concluded that the efficacy of this medication as a standalone treatment compared favorably to ICE-based regimens.

"Given the results, we will continue to explore the role of pralatrexate in combination with other agents to build upon its single agent activity. Our investigation will include PTCL patients in relapse and in the frontline setting in an effort to improve outcomes," said Dr. Goy.

Response of Multiple Myeloma Patients to Carfilzomib After Other Treatments Have Failed (Abstract number 985; oral session, December 7, 7:30 a.m.)

A new proteasome inhibitor may hold hope for patients with multiple myeloma who have been treated unsuccessfully with other drugs. Dr. Siegel and colleagues conducted an open-label single-arm phase 2b study of carfilzomi
'/>"/>

Contact: Amy Leahing
amy.leahing@gmail.com
305-458-0599
John Theurer Cancer Center
Source:Eurekalert

Page: 1 2 3 4 5 6 7

Related medicine news :

1. The John Theurer Cancer Center to unveil 40 presentations at the 52nd ASH Annual Meeting
2. John Theurer Cancer Center to present innovative research at 2 surgical meetings
3. John Theurer Cancer Center first cancer center in N.J. to acquire new radiotherapy system
4. John Theurer Cancer Center and LLS host panel discussion with leading hematologists
5. The John Theurer Cancer Center recognizes medical physics team for safety track record
6. John Theurer Cancer Center experts present new cancer research at ASCO Annual Meeting
7. Leading physicians and researchers at the John Theurer Cancer Center present research at ASCO
8. John Theurer Cancer Center offers breakthrough radiation measurement technology
9. John Theurer Cancer Center hosts hematologic malignancies program for physicians and patients
10. Low-dose aspirin reduces death rates from range of cancers by between 20 and 30 percent
11. Daily Aspirin Linked to Steep Drop in Cancer Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2015)... May 24, 2015 EnviroLeather™ by ... “InkGard™ Plus” – a classic, rugged leather grain ... allowing difficult stains, including ink, to be easily ... colors suitable for corporate, healthcare, hospitality and education ... with EnviroLeather’s goal of developing products that are ...
(Date:5/24/2015)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Inc. (MTA) has selected IFN as a fiber transport ... Sales Manager, fiber route diversity and network redundancy are ... MTA with the diverse fiber transport from their Merrillville ... voice carriers located at Henry Street in Indianapolis, IN. ...
(Date:5/24/2015)... A report out just last month ... option for avoiding cardiovascular disease is exercise and maintaining ... single most powerful predictor of death and survival, even ... family history of premature death -- a finding that ... fitness. , The Importance of Cardiovascular Screening , The ...
(Date:5/23/2015)... Beach, CA (PRWEB) May 23, 2015 Dr. ... Beach, California, has just posted a new article ... gauge repair. As Dr Benvenuti explained in the ... wear enlarged plugs in their earlobes. , Known as “gauging,” ... the earlobe hole, which Dr. Benvenuti said will eventually stretch ...
(Date:5/23/2015)... On May 16, the team at Farrell’s eXtreme ... mud obstacle run that raised funds for multiple sclerosis. ... the reason we participated was to support people living with ... eXtreme Bodyshaping. “One-hundred percent of the funds raised go to ... not only attended by eXtreme Bodyshaping staff, but members of ...
Breaking Medicine News(10 mins):Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2Health News:Indiana Fiber Network, LLC Enables Midwest Telecom of America with Fiber Route Diversity 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 2Health News:Recent Mayo Clinic Studies Help to Highlight the Value of Cardio Testing 3Health News:Dr. Benvenuti, a Plastic Surgeon in Newport Beach, CA, Posts New Article about Repairing Ear Gauges 2Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2
... PARK, N.C., Sept. 24 TransEnterix, an,early-stage, privately-held ... announced today that the Board of Directors has,named ... Chief Executive,Officer. Mr. Pope has spent nearly 20 ... cardiovascular, peripheral vascular, neurovascular, and,laparoscopic surgery., Mr. ...
... Program Prompted by Nearly 30 Million Annual Childhood ED ... ... a child to the,emergency department (ED) is a journey that parents dread ... many,families will face this experience at some point in their lives. To ...
... New innovative treatment approaches in Alzheimer,s disease which ... amyloid plaques have emerged as the leading candidates ... approaches were presented at ICAD 2008, the world,s ... are discussed in the debut of AlzheimerVideoNews.com, a ...
... Recognition, WASHINGTON, Sept. 24 Twenty-six hospitals ... Hospitals, based on results,of the Leapfrog Hospital Survey. ... evaluation tool and provides consumers and health,care purchasers ... safety at its Web site, http://www.leapfroggroup.org ., ...
... ... Nashville, TN (Vocus) September 24, 2008 -- www.mmc.edu [Meharry ... September 29 at 9 a.m. with an outdoor ceremony in the ... two non African-American graduates of Meharry will be honored at the ...
... cosmetic skin treatment field this year when it debuted its ... clinic Juva Skin & Laser Center is making that advanced ... , ... (PRWEB) September 24, 2008 ...
Cached Medicine News:Health News:TransEnterix Inc. Names Experienced Medical Device Executive Todd M. Pope as President, CEO 2Health News:Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit 2Health News:Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit 3Health News:Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit 4Health News:Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit 5Health News:Child Life Council Urges Parents to Think Ahead to Ease Child's Hospital Visit 6Health News:World Alzheimer's Day 2008 Special Report: New Alzheimer Targets Take Center Stage 2Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 2Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 3Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 4Health News:Leapfrog Group's 2008 Top Hospitals Excel at Patient Safety 5Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 2Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 3Health News:First Two Non African-American Graduates of Meharry Medical College to Receive Awards at 2008 Fall Convocation 4Health News:New York City Skin Care Leader Juva Offering Latest Skin Resurfacing Innovation 2
(Date:5/22/2015)... Md. , May 22, 2015  RegeneRx Biopharmaceuticals, ... on tissue protection, repair and regeneration, today announced that ... is scheduled to present a corporate overview at two ... present at the SeeThruEquity 4 th Annual Microcap ... New York City at 11:00 am EDT. ...
(Date:5/22/2015)... May 22, 2015  RegeneRx Biopharmaceuticals, Inc. (OTCQB: ... peer-reviewed publication of the results of the Company,s ... preservative-free eye drops) for the treatment of dry ... (CAE ® ) model.  The exploratory study was ... were previously disseminated by the Company in a ...
(Date:5/22/2015)... , May 20, 2015 Research ... of the "Guide to Prepare Application Dossiers ... China (2014 Edition) " report to their ... is one of segment market of the most ... overseas medical device manufacturers and producers to penetrate ...
Breaking Medicine Technology:RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 4China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 3
... Inc., a privately held biopharmaceutical company that specializes ... ophthalmic pharmaceuticals, today reported that an independent Data ... of two pivotal Phase 3 clinical trials for ... diabetic macular edema (DME) under the current protocol, ...
... April 7 Glycotex, Inc. today announced the completion ... study evaluating the effect of investigational GLYC-101 gel on ... patients undergoing carbon dioxide laser skin resurfacing on the ... subjects completed the study. The comparison of each active ...
Cached Medicine Technology:Alimera Sciences' Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout 2Alimera Sciences' Iluvien(TM) Phase 3 Studies for DME Pass Final DSMB Review Prior to October Readout 3Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 2Glycotex' Investigational Compound GLYC-101 Achieves Accelerated Wound Closure Based on Interim Analysis 3
... provide a broad selection of tip ... variety of ophthalmic procedures. Each single ... with a safety cap to lock ... when not in use, and carries ...
... broad selection of tip styles for ... ophthalmic procedures. Each single use cautery ... safety cap to lock switch in ... in use, and carries a 3-4 ...
... Accu-Temp Cauteries provide a broad ... in a wide variety of ophthalmic ... packaged sterile, complete with a safety ... "off " position when not in ...
... The B-VAT® PC visual acuity system allows ... of the B-VAT II. The system includes ... contrast sensitivity testing and animated characters. Random ... operator has single letter, single line and ...
Medicine Products: